[Percutaneous coronary interventions in patients with ischemic heart disease and chronic renal failure].
Patients with chronic renal failure (CRF) consist of about 10% of all patients with ischemic heart disease (IHD) undergoing percutaneous coronary interventions (PCI). These patients have a higher rate of in-hospital and long-term major adverse cardiac events. Coronary stents improved prognosis in CRF patients, however long-term survival is still poor. Coronary artery bypass graft (CABG) surgery is an alternative modality of treatment, with better long-term prognosis but at the cost of higher in-hospital mortality. CABG surgery probably should be preferred in patients with CRF and multivessel coronary artery disease, left main stenosis or diabetes. The influence of drug-eluting stents on survival in patients with CRF is unknown.